ONMD (OneMedNet) Moat Score: 3/10 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ONMD OneMedNet Corp ONMD
8 GF Score
Price $0.65
GF Value $0.57
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is OneMedNet Moat Score?

OneMedNet ONMD -3.76% 8 Moat Score is 3 as of Jul. 21, 2026. GuruFocus rates ONMD with a GF Score™ of 8/100 and a GF Value™ of $0.57 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 673 Healthcare Providers & Services companies, OneMedNet ranks better than 84.4% on this metric.

OneMedNet has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

OneMedNet has No Moat: OneMedNet Corp does not demonstrate significant market leadership or customer loyalty. The company lacks valuable intellectual property, strong brand strength, and durable cost advantages, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes OneMedNet might have No Moat - Very weak/transient advantages.

OneMedNet  (NAS:ONMD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

OneMedNet Moat Score Related Terms

ONMD vs CRVW, BEAT, VASO: Moat Score Comparison

For the Health Information Services subindustry, OneMedNet's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OneMedNet Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OneMedNet's Moat Score distribution charts can be found below:

* The bar in red indicates where OneMedNet's Moat Score falls into.


ONMD
8GF Score
OneMedNet Corp ONMD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
OneMedNet (ONMD) has a Moat Score of 3 as of Jul. 21, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, OneMedNet ranks #105 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 15.6%.
Is OneMedNet's Moat Score too high?
OneMedNet's current Moat Score is 3. Based on the distribution chart, OneMedNet ranks #105 out of 673 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, OneMedNet has a GF Score™ of 8/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OneMedNet's Moat Score compare to CRVW and BEAT?
According to the Healthcare Providers & Services industry distribution chart, OneMedNet ranks #105 out of 673 companies for Moat Score. This places OneMedNet in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. OneMedNet's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneMedNet stock overvalued right now?
Based on GuruFocus' analysis, OneMedNet (ONMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.57, compared to a current price of $0.65 — trading 13.9% above its estimated fair value. The current Moat Score is 3. OneMedNet's overall GF Score™ is 8/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For OneMedNet (ONMD), the current Moat Score is 3 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OneMedNet (ONMD) Overvalued in 2026?

Based on GuruFocus' analysis, OneMedNet stock appears to be overvalued. The current stock price of $0.65 is trading 13.9% above its estimated GF Value™ of $0.57. GuruFocus considers OneMedNet to be Modestly Overvalued.

Key valuation signals for ONMD:

  • Moat Score: 3
  • GF Value™: $0.57 vs. price of $0.65 (13.9% above fair value)
  • GF Score™: 8/100 with 8 warning signs

No single metric tells the full story. See the ONMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OneMedNet Business Description

Address 6385 Old Shady Oak Road, Suite 250, Eden Prairie, MN, USA, 55344
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.
8GF Score

Get the complete analysis for ONMD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.57
GF Value